Halma buys Rovers Medical for €85m
Halma
2,219.00p
16:35 26/04/24
1.88%
41.00p
Health tech company Halma on Monday said it had bought Netherlands-based Rovers Medical Devices for €85m (£73m).
Electronic & Electrical Equipment
9,721.29
16:59 26/04/24
1.20%
115.42
FTSE 100
8,139.83
17:09 26/04/24
n/a
n/a
FTSE 350
4,470.09
16:59 26/04/24
n/a
n/a
FTSE All-Share
4,423.59
17:14 26/04/24
n/a
n/a
Rovers designs and makes sample collection devices used in the prevention and diagnostics of cervical cancer, Halma said in a statement. An extra payment of €6m is payable in cash, based on Rovers' performance in the period to March 31, 2025.
Unaudited revenue for the 12 months to 31 December 2023 was €12.0m, with return on sales more than double Halma's target range of 18-22%. Rovers will be a standalone company within Halma's Healthcare sector, led by its current management team, Halma added.
Reporting by Frank Prenesti for Sharecast.com